4.7 Review

Adiponectin and Vulnerable Atherosclerotic Plaques

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 57, Issue 7, Pages 761-770

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2010.11.011

Keywords

acute coronary syndrome; adventitia; atherosclerosis; biomarkers; intraplaque hemorrhage; necrotic core; plaque rupture; thin-cap fibroatheroma; vasa vasorum

Funding

  1. Takeda
  2. Amylin
  3. Eli Lilly
  4. Novartis

Ask authors/readers for more resources

High-risk plaques that are vulnerable to rupture demonstrate distinct morphological characteristics. They are differentiated from the lesions responsible for stable coronary artery disease by their large necrotic cores, thin-inflamed fibrous caps, and positive remodeling. Adiponectin is an adipocytokine that is reduced in obesity and type 2 diabetes. Hypoadiponectinemia has been associated with an increased risk of coronary artery disease and acute coronary syndrome in several though not all studies. The involvement of adiponectin provides clues to the inflammatory and atherogenic mechanisms associated with pathological coronary disease progression. (J Am Coll Cardiol 2011; 57: 761-70) (C) 2011 by the American College of Cardiology Foundation

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available